
Mary Mosher
Examiner (ID: 10578)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1641, 1805, 2899, 1813, 1648, 1804, 1643, 1815, 1609 |
| Total Applications | 1434 |
| Issued Applications | 907 |
| Pending Applications | 126 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5642268
[patent_doc_number] => 20060280723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Interferon for treating or preventing a coronaviral infection'
[patent_app_type] => utility
[patent_app_number] => 10/557761
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7199
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20060280723.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557761
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557761 | Interferon for treating or preventing a coronaviral infection | May 18, 2004 | Abandoned |
Array
(
[id] => 7327080
[patent_doc_number] => 20040253273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents'
[patent_app_type] => new
[patent_app_number] => 10/848620
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7565
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848620
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848620 | Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents | May 16, 2004 | Abandoned |
Array
(
[id] => 6997376
[patent_doc_number] => 20050137154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Treating server acute respiratory syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/842474
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2824
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137154.pdf
[firstpage_image] =>[orig_patent_app_number] => 10842474
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/842474 | Treating server acute respiratory syndrome | May 10, 2004 | Abandoned |
Array
(
[id] => 7423736
[patent_doc_number] => 20040265377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Solid dispersing vaccine composition for oral delivery'
[patent_app_type] => new
[patent_app_number] => 10/835680
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5515
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265377.pdf
[firstpage_image] =>[orig_patent_app_number] => 10835680
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/835680 | Solid dispersing vaccine composition for oral delivery | Apr 29, 2004 | Abandoned |
Array
(
[id] => 190750
[patent_doc_number] => 07642061
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-05
[patent_title] => 'Glut-1 as a receptor for HTLV envelopes and its uses'
[patent_app_type] => utility
[patent_app_number] => 10/555289
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11219
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/642/07642061.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555289
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555289 | Glut-1 as a receptor for HTLV envelopes and its uses | Apr 29, 2004 | Issued |
Array
(
[id] => 5733460
[patent_doc_number] => 20060258577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'ANTIVIRAL AGENTS FOR THE TREATMENT, CONTROL AND PREVENTION OF INFECTIONS BY CORONAVIRUSES'
[patent_app_type] => utility
[patent_app_number] => 10/833304
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6362
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258577.pdf
[firstpage_image] =>[orig_patent_app_number] => 10833304
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/833304 | Antiviral agents for the treatment, control and prevention of infections by coronaviruses | Apr 27, 2004 | Issued |
Array
(
[id] => 7372138
[patent_doc_number] => 20040219170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Viruses encoding mutant membrane protein'
[patent_app_type] => new
[patent_app_number] => 10/827995
[patent_app_country] => US
[patent_app_date] => 2004-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 15909
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219170.pdf
[firstpage_image] =>[orig_patent_app_number] => 10827995
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/827995 | Viruses encoding mutant membrane protein | Apr 19, 2004 | Issued |
Array
(
[id] => 7250011
[patent_doc_number] => 20050142109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Method of treatment using interferon-tau'
[patent_app_type] => utility
[patent_app_number] => 10/824710
[patent_app_country] => US
[patent_app_date] => 2004-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16427
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142109.pdf
[firstpage_image] =>[orig_patent_app_number] => 10824710
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/824710 | Method of treatment using interferon-tau | Apr 13, 2004 | Issued |
Array
(
[id] => 7060545
[patent_doc_number] => 20050002905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'RAAV vector-based pro-opiomelanocortin compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/822613
[patent_app_country] => US
[patent_app_date] => 2004-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 51277
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002905.pdf
[firstpage_image] =>[orig_patent_app_number] => 10822613
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/822613 | RAAV vector-based pro-opiomelanocortin compositions and methods of use | Apr 11, 2004 | Abandoned |
Array
(
[id] => 6997348
[patent_doc_number] => 20050137126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Treatment of SARS in individuals'
[patent_app_type] => utility
[patent_app_number] => 10/820155
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10046
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137126.pdf
[firstpage_image] =>[orig_patent_app_number] => 10820155
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/820155 | Treatment of SARS in individuals | Apr 7, 2004 | Abandoned |
Array
(
[id] => 5182533
[patent_doc_number] => 20070053878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Sars'
[patent_app_type] => utility
[patent_app_number] => 10/552755
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 18047
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053878.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552755
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552755 | Sars | Apr 7, 2004 | Abandoned |
Array
(
[id] => 654448
[patent_doc_number] => 07108967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-19
[patent_title] => 'Hepatitis C viral antigen immunoassay detection systems'
[patent_app_type] => utility
[patent_app_number] => 10/820922
[patent_app_country] => US
[patent_app_date] => 2004-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 8736
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/108/07108967.pdf
[firstpage_image] =>[orig_patent_app_number] => 10820922
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/820922 | Hepatitis C viral antigen immunoassay detection systems | Apr 6, 2004 | Issued |
Array
(
[id] => 330332
[patent_doc_number] => 07510827
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-31
[patent_title] => 'Compositions and methods for detecting certain Flaviviruses, including members of the Japanese encephalitis virus serogroup'
[patent_app_type] => utility
[patent_app_number] => 10/815480
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 11
[patent_no_of_words] => 30005
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/510/07510827.pdf
[firstpage_image] =>[orig_patent_app_number] => 10815480
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/815480 | Compositions and methods for detecting certain Flaviviruses, including members of the Japanese encephalitis virus serogroup | Mar 30, 2004 | Issued |
Array
(
[id] => 7060541
[patent_doc_number] => 20050002901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Compositions and methods for treating coronavirus infection and SARS'
[patent_app_type] => utility
[patent_app_number] => 10/814701
[patent_app_country] => US
[patent_app_date] => 2004-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26780
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002901.pdf
[firstpage_image] =>[orig_patent_app_number] => 10814701
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/814701 | Compositions and methods for treating coronavirus infection and SARS | Mar 29, 2004 | Abandoned |
Array
(
[id] => 91356
[patent_doc_number] => 07731974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Mutant vesicular stomatitis viruses and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/551103
[patent_app_country] => US
[patent_app_date] => 2004-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 39
[patent_no_of_words] => 17731
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/731/07731974.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551103
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551103 | Mutant vesicular stomatitis viruses and uses thereof | Mar 28, 2004 | Issued |
Array
(
[id] => 5784259
[patent_doc_number] => 20060204475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Melan-a peptide analogue-virus-like-particle conjugates'
[patent_app_type] => utility
[patent_app_number] => 10/551054
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 47816
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204475.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551054
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551054 | Melan-A- carrier conjugates | Mar 24, 2004 | Issued |
Array
(
[id] => 7126920
[patent_doc_number] => 20050058664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant IBDV strains'
[patent_app_type] => utility
[patent_app_number] => 10/809176
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10192
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058664.pdf
[firstpage_image] =>[orig_patent_app_number] => 10809176
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/809176 | Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant IBDV strains | Mar 23, 2004 | Issued |
Array
(
[id] => 7285785
[patent_doc_number] => 20040146487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Avidin pseudotyped viral vectors and their use'
[patent_app_type] => new
[patent_app_number] => 10/471488
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2275
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146487.pdf
[firstpage_image] =>[orig_patent_app_number] => 10471488
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/471488 | Avidin pseudotyped viral vectors and their use | Mar 14, 2004 | Abandoned |
Array
(
[id] => 5171344
[patent_doc_number] => 20070071775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination'
[patent_app_type] => utility
[patent_app_number] => 10/546410
[patent_app_country] => US
[patent_app_date] => 2004-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12913
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20070071775.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546410
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546410 | Vibrio cholerae with improved biological safety features in freeze dried form | Feb 18, 2004 | Issued |
Array
(
[id] => 7322339
[patent_doc_number] => 20040136984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Mammalian galanin receptors'
[patent_app_type] => new
[patent_app_number] => 10/779021
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11016
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20040136984.pdf
[firstpage_image] =>[orig_patent_app_number] => 10779021
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/779021 | Mammalian galanin receptors | Feb 12, 2004 | Abandoned |